Genetic Circuit Cell Programming for Rapid Chondrogenic Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for converting stem cells into chondrogenic cells are inefficient and time-consuming, often taking more than 7 days to achieve a significant conversion rate.
Innovation Solution
Utilizing a genetic circuit with heterologous proteins and nucleic acid molecules to modulate the expression levels of specific homeobox proteins and other transcription factors in stem cells, enabling rapid conversion to chondrogenic cells within less than 7 days, with a conversion rate of at least 30%.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional methods are used to convert stem cells into chondrogenic cells, then the conversion process is slow and time-consuming, but the methods are simpler and more established
Solution Approach 1:
The patent applies parameter changes by systematically optimizing multiple parameters including: (1) combinatorial expression of transcription factors (SOX9, RUNX2, RUNX3), (2) culture medium composition (growth factors, hormones, supplements), (3) mechanical stimulation parameters (frequency, amplitude, duration), and (4) culture conditions (oxygen tension, pH, temperature). This multi-parameter optimization enables achieving ≥30% conversion rate within 7 days, resolving the contradiction between conversion efficiency and time consumption.
2Loss of time
If rapid conversion is achieved through intensified culture conditions, then conversion time is reduced, but the complexity of the culture system increases
Solution Approach 1:
The patent segments the conversion process into distinct phases with specific parameter sets: (1) initial differentiation phase with specific growth factors, (2) chondrogenic commitment phase with altered medium composition, and (3) maturation phase with mechanical stimulation. This segmentation allows rapid conversion without requiring all complex parameters simultaneously, reducing overall system complexity while maintaining speed.
Solution Approach 2:
The patent applies preliminary action by pre-determining optimal parameter combinations through systematic screening before actual conversion. The culture system is pre-configured with optimized growth factor concentrations, hormone levels, and mechanical stimulation protocols based on preliminary experiments, enabling rapid conversion without needing to adjust complex parameters during the process.
Data Source
AI summary
Provided herein are systems of modulating gene expression, methods of use thereof, and cells engineered thereof for the purpose of differentiating cells, for example chondroprogenitor cells.